|
Volumn 95, Issue 11, 2003, Pages 774-775
|
Work on breast cancer stem cells raises questions about treatment strategies
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ACUTE GRANULOCYTIC LEUKEMIA;
BONE MARROW;
BREAST CANCER;
BREAST CARCINOGENESIS;
CANCER GROWTH;
CANCER RECURRENCE;
CELL DIFFERENTIATION;
CELL DIVISION;
CELL ISOLATION;
CELL POPULATION;
CELL PROLIFERATION;
CELL RENEWAL;
CELL TRANSFORMATION;
DRUG EFFICACY;
DRUG TARGETING;
GENE EXPRESSION;
HUMAN;
METASTASIS;
MINIMAL RESIDUAL DISEASE;
NOTE;
PRIORITY JOURNAL;
STEM CELL;
TERATOCARCINOMA;
TUMOR VOLUME;
ANIMAL;
ARTICLE;
BREAST TUMOR;
CANCER STEM CELL;
FEMALE;
PATHOLOGY;
ANIMALS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
TUMOR STEM CELLS;
|
EID: 0037704262
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.11.774 Document Type: Note |
Times cited : (2)
|
References (0)
|